首页> 美国卫生研究院文献>other >Modular polyketide synthases and cis-double bond formation: Establishment of activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in phoslactomycin biosynthesis
【2h】

Modular polyketide synthases and cis-double bond formation: Establishment of activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in phoslactomycin biosynthesis

机译:模块化聚酮化合物合酶和顺式双键的形成:活化顺式-3-环己基丙酸作为磷脂酰菌素生物合成中的二酮中间体的建立

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The majority of modular polyketide synthase (PKS) systems which generate unsaturated products do so with trans double bonds. Phoslactomycin B (PLM B) presents a class of antitumor and antiviral natural polyketide products that have unique structural features, including a linear unsaturated backbone with one trans and three cis double bonds. There is substantial evidence that trans double bonds are established by ketoreductase-dehydratase (KR-DH) didomains within a PKS module. In cases where modules containing these didomains appear to generate product containing a cis double bond there is no experimental evidence to determine if they do so directly, or if they also form a trans double bond with a subsequent isomerization step. A critical step in addressing this issue is establishing the stereochemistry of the polyketide intermediate which passes to the subsequent module. Herein, we demonstrate through a series of experiments that an activated cis-3-cyclohexylpropenoic acid is the diketide intermediate which passes from module 1 to module 2 of the PLM PKS. The trans isomer of the diketide intermediate could not be processed directly into PLM B by module 2, but could be converted to PLM B by degradation to cyclohexanecarboxylic acid and elongation by the entire PLM PKS. These observations indicate not only that module 1 with a DH-KR didomain is responsible for establishing C14–C15 cis double bond of PLM B, but that the subsequent modules of the PKS clearly discriminate between the cis and trans-diketide intermediate and do not contain domains capable of catalyzing double bond isomerization.
机译:产生不饱和产物的大多数模块化聚酮化合物合酶(PKS)系统都带有反式双键。磷霉素B(PLM B)提供了一类具有独特结构特征的抗肿瘤和抗病毒天然聚酮化合物,包括带有一个反式和三个顺式双键的线性不饱和骨架。有大量证据表明,PKS模块中的酮还原酶脱水酶(KR-DH)双结构域可建立反式双键。在含有这些双结构域的模块似乎产生含有顺式双键的产物的情况下,没有实验证据确定它们是否直接这样做,或者它们是否在随后的异构化步骤中也形成了反式双键。解决此问题的关键步骤是建立传递至后续模块的聚酮化合物中间体的立体化学。在此,我们通过一系列实验证明,活化的顺式3-环己基丙酸是从PLM PKS的模块1到模块2传递的二酮化合物中间体。双酮化合物中间体的反式异构体不能通过模块2直接加工成PLM B,但可以通过降解成环己烷羧酸和整个PLM PKS延长而转化为PLMB。这些观察结果不仅表明具有DH-KR双结构域的模块1负责建立PLM B的C14–C15顺式双键,而且随后的PKS模块清楚地区分了顺式和反二酮化合物中间体,并且不包含能够催化双键异构化的结构域。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号